Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality.
Joseph M RoccoPaola LaghettiMariantonietta Di StefanoIrini SeretiAna Ortega-VillaJing WangAdam RupertMaria ChironnaLara YeXiangdong LiuMegan V AndersonPeter B BurbeloJose Ramon FioreAnnalisa SaracinoAndrea LiscoPublished in: Open forum infectious diseases (2022)
In this study, abnormal levels of myeloid activation, endothelial damage, and innate immune markers were associated with severe coronavirus disease 2019 (COVID-19), while higher levels of metabolic biomarkers (irisin, leptin) demonstrated a protective effect. These data support a model for COVID-19 immunopathogenesis linking robust inflammation and endothelial damage in metabolically predisposed individuals.